Literature DB >> 20012434

The clinicopathological analysis of 303 cases with malignant lymphoma classified according to the World Health Organization classification system in a single institute of Taiwan.

Wei-Liang Chen1, Wen-Chiuan Tsai, Tsu-Yi Chao, Lai-Fa Sheu, Jung-Mao Chou, Woei-Yau Kao, Yeu-Chin Chen, Ching-Liang Ho.   

Abstract

Several reports have shown a different distribution of malignant lymphoma (ML) in Asian and Western populations. The purpose of our survey was to elucidate whether there are substantial differences in the frequencies of subtypes of ML between different geographical areas. All entities diagnosed as ML between June 1995 and December 2007 were selected according to the 2008 World Health Organization (WHO) classification and searched for clinical outcomes. The cases were retrieved and reviewed by a panel of clinical haematologists and haematopathologists. A total of 303 patients with ML were identified for retrospective analysis. Of the 303 patients with ML, 278 patients (91.7%) had non-Hodgkin's lymphoma (NHL), and 25 (9.2%) had Hodgkin's lymphoma. Of the 278 patients with NHL, 223 (73.6%) had lymphoma of B-cell lineage, and 55 (18.1%) had lymphoma of T-cell lineage. One hundred and thirty-seven patients were diagnosed with diffuse large B-cell lymphoma, which was the most common B-cell lineage subtype and accounted for 45.2% of patients with NHL. Peripheral T-cell lymphomas were the most frequent subset of the T-cell neoplasms, comprising 10.6% of ML. Extranodal involvement was found in 125 (44.9%) of the 278 patients with NHL, and the lymph node was the site of primary involvement in 153 patients (55.1%). Fifty-nine (47.2%) of the 125 patients with extranodal presentation had gastrointestinal tract involvement. Outcome was worse in patients with extranodal NHL than in those with nodal NHL through the entire follow-up period; the difference in survival rates was significant. Our findings clarify the applicability and prognostic relevance of the WHO classification system and provide further information about the incidence of various lymphoma subtypes in Taiwan. Primary extranodal NHL was associated with a worse prognosis and distinct characteristics compared with nodal NHL. The outcome of different types of extranodal NHL should be investigated further.

Entities:  

Mesh:

Year:  2009        PMID: 20012434     DOI: 10.1007/s00277-009-0870-z

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  14 in total

Review 1.  T-cell lymphoma with von Hippel-Lindau disease: a rare case report and review of literature.

Authors:  Li-Hong Lou; Hua Shen; Jun Lin; Yi-Wen Yan; Yan Peng; Jian-Hong Lu; Qu Xu; Hai-Qiong Jiang
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

2.  Development of second primary malignancy in patients with non-Hodgkin lymphoma: a nationwide population-based study.

Authors:  Sheng-Hsuan Chien; Chia-Jen Liu; Ying-Chung Hong; Chung-Jen Teng; Yu-Wen Hu; Fan-Chen Ku; Chiu-Mei Yeh; Tzeon-Jye Chiou; Jyh-Pyng Gau; Cheng-Hwai Tzeng
Journal:  J Cancer Res Clin Oncol       Date:  2015-05-14       Impact factor: 4.553

Review 3.  Peripheral T and NK cell non-hodgkin lymphoma a challenge for diagnosis.

Authors:  Daniela Vasile; Ana-Maria Vladareanu; Horia Bumbea
Journal:  Maedica (Buchar)       Date:  2014-03

4.  LBD: a manually curated database of experimentally validated lymphoma biomarkers.

Authors:  Bin Tan; Saige Xin; Yanshi Hu; Cong Feng; Ming Chen
Journal:  Database (Oxford)       Date:  2022-07-05       Impact factor: 4.462

Review 5.  From drug discovery to biomarker-driven clinical trials in lymphoma.

Authors:  Anas Younes; Donald A Berry
Journal:  Nat Rev Clin Oncol       Date:  2012-09-11       Impact factor: 66.675

6.  Subtype distribution of lymphomas in Southwest China: analysis of 6,382 cases using WHO classification in a single institution.

Authors:  Qun-Pei Yang; Wen-Yan Zhang; Jian-Bo Yu; Sha Zhao; Huan Xu; Wei-Ya Wang; Cheng-Feng Bi; Zhuo Zuo; Xiao-Qing Wang; Juan Huang; Lin Dai; Wei-Ping Liu
Journal:  Diagn Pathol       Date:  2011-08-22       Impact factor: 2.644

7.  Previous Exposure to Statin May Reduce the Risk of Subsequent Non-Hodgkin Lymphoma: A Nationwide Population-Based Case-Control Study.

Authors:  Shih-Feng Cho; Yi-Hsin Yang; Yi-Chang Liu; Hui-Hua Hsiao; Chiung-Tang Huang; Cheng-Han Wu; Yu-Fen Tsai; Hui-Ching Wang; Ta-Chih Liu
Journal:  PLoS One       Date:  2015-10-01       Impact factor: 3.240

8.  How to predict the outcome in mature T and NK cell lymphoma by currently used prognostic models?

Authors:  H-N Lin; C-Y Liu; J-T Pai; F-P Chang; C-F Yang; Y-B Yu; L-T Hsiao; T-J Chiou; J-H Liu; J-P Gau; C-H Tzeng; P-M Chen; Y-C Hong
Journal:  Blood Cancer J       Date:  2012-10-12       Impact factor: 11.037

9.  Lymphotoxin alpha (LTA) polymorphism is associated with prognosis of non-Hodgkin's lymphoma in a Chinese population.

Authors:  Yan Zhang; Min-Bin Chen; Xiao-Yan Zhou; Xiao-Nan Hong
Journal:  PLoS One       Date:  2013-06-20       Impact factor: 3.240

10.  Herpes zoster is associated with an increased risk of subsequent lymphoid malignancies - a nationwide population-based matched-control study in Taiwan.

Authors:  Yi-Chang Liu; Yi-Hsin Yang; Hui-Hua Hsiao; Wen-Chi Yang; Ta-Chih Liu; Chao-Sung Chang; Ming-Yu Yang; Pai-Mei Lin; Jui-Feng Hsu; Pi-Yu Chang; Sheng-Fung Lin
Journal:  BMC Cancer       Date:  2012-10-31       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.